$0.280
-0.021 (-7.49%)At close
Technical Sentiment
Overall Consensus
Technical Analysis Consensus
Moving Average Consensus
Mereo BioPharma Group PLC (MREO) Moving Averages Convergence Divergence (MACD) indicator is -0.01, suggesting MREO is Strong sell.
Mereo BioPharma Group PLC (MREO) 20-Day simple moving average is 0.30, while Mereo BioPharma Group PLC (MREO) share price is $—, making it Sell.
Mereo BioPharma Group PLC (MREO) 60-Day simple moving average is 0.30, while Mereo BioPharma Group PLC (MREO) share price is $—, making it Sell.
Technical Analysis for MREO
AI Technical MREOAs of 2026-11-03, the technical board for Mereo BioPharma Group PLC (MREO) reads strong sell: 2 indicators are flashing buy, 8 are indicating sell, and 3 are neutral. Price at $0.28 sits below every tracked moving average (5-day, 10-day, 20-day, 60-day and 200-day).
Momentum readings: RSI stands at 42.46, MACD stands at -0.00911 (Sell), Stochastic %K stands at 29.943, Stochastic %D stands at 34.163 and CCI stands at -112.972 (Buy).
MREO trades below the 60-day SMA (0.30) and below the 200-day SMA (0.33). Immediate resistance sits at Classic R1 0.32, then R2 0.35. Support sits at Classic S1 0.27, then S2 0.24.
Mereo BioPharma Group PLC (MREO) Support & Resistance Level
Mereo BioPharma Group PLC (MREO) Technical Indicators
2026-11-03
| Name | Value |
|---|---|
| RSI_14 | 42.460 |
| STOCHk_14_3_3 | 29.943 |
| STOCHd_14_3_3 | 34.163 |
| CCI_20 | -112.972 |
| AO_5_34 | -0.035 |
| MOM_10 | 0.001 |
| MACD_12_26_9 | -0.009 |
Mereo BioPharma Group PLC (MREO) Relative Strength Index (RSI_14) is 42.460, creating a Neutral signal.
Mereo BioPharma Group PLC (MREO) Stochastic %K is 29.943, creating a Neutral signal.
Mereo BioPharma Group PLC (MREO) Stochastic %D is 34.163, creating a Neutral signal.
Mereo BioPharma Group PLC (MREO) CCI_20 is -112.972, creating a Buy signal.
Mereo BioPharma Group PLC (MREO) Awesome Oscillator (AO) is -0.035, creating a Sell signal.
Mereo BioPharma Group PLC (MREO) Momentum (MOM) is 0.001, creating a Buy signal.
Mereo BioPharma Group PLC (MREO) Moving Average Convergence Divergence (MACD) is -0.009, creating a Sell signal.
Mereo BioPharma Group PLC (MREO) Moving Average
2026-11-03
| Period | Simple | Signal |
|---|---|---|
| MA_5 | 0.289 | Sell |
| MA_10 | 0.290 | Sell |
| MA_20 | 0.296 | Sell |
| MA_60 | 0.304 | Sell |
| MA_200 | 0.326 | Sell |
| MA_250 | 0.556 | Sell |
Mereo BioPharma Group PLC (MREO) 5-Day simple moving average is 0.289, while Mereo BioPharma Group PLC (MREO) share price is $, making it a Sell.
Mereo BioPharma Group PLC (MREO) 10-Day simple moving average is 0.290, while Mereo BioPharma Group PLC (MREO) share price is $, making it a Sell.
Mereo BioPharma Group PLC (MREO) 20-Day simple moving average is 0.296, while Mereo BioPharma Group PLC (MREO) share price is $, making it a Sell.
Mereo BioPharma Group PLC (MREO) 60-Day simple moving average is 0.304, while Mereo BioPharma Group PLC (MREO) share price is $, making it a Sell.
Mereo BioPharma Group PLC (MREO) 200-Day simple moving average is 0.326, while Mereo BioPharma Group PLC (MREO) share price is $, making it a Sell.
Mereo BioPharma Group PLC (MREO) 250-Day simple moving average is 0.556, while Mereo BioPharma Group PLC (MREO) share price is $, making it a Sell.
Related articles
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.